Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy

NCT02351102 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02351102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
Lead sponsor
Rabin Medical Center
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2015
Completion date
July 31, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital cytomegalovirus infection